Between a Rock and a Hard Place: The Weight-Loss Drug Dilemma
Few medical breakthroughs have captured the public’s imagination or insurance budgets, quite like the new class of weight-loss drugs. Medications like Ozempic and Wegovy, originally developed to treat diabetes, have exploded in popularity, promising not just slimmer waistlines but improved overall health. Yet, the rising costs of these drugs are forcing states and insurers into Read More “Between a Rock and a Hard Place: The Weight-Loss Drug Dilemma”